-
Sanofi Unveils EUROAPI as Name of New European API Company
contractpharma
January 18, 2021
Sanofi has choosen EUROAPI as the name for the future European company dedicated to the development, production and marketing of active pharmaceutical ingredients (APIs).
-
Sai Life Sciences to recruit over 500 scientists in 2021
expresspharma
December 18, 2020
Initiates first phase of recruitment for 100 scientists in API process development and scale-up.
-
Recipharm Expands API Manufacturing Capabilities
contractpharma
December 10, 2020
Global contract development and manufacturing organization (CDMO), Recipharm, has unveiled an investment and capacity expansion at its facility in Israel.
-
Piramal Pharma Solutions invests ~$32 mn in its Riverview Michigan facility
expresspharma
December 10, 2020
Piramal Pharma’s Pharma Solutions business announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharma ingredients (APIs).
-
Piramal Invests $32M to Expand Michigan Facility
contractpharma
December 09, 2020
Piramal Pharma Solutions (PPS) is investing $32 million to expand its facility in Riverview, MI with additional capacity and new capabilities for the development and manufacture of Active Pharmaceutical Ingredients (APIs).
-
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
contractpharma
November 26, 2020
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.
-
Govt of India is committed to improvement of pharma profession and industry: Gowda
expresspharma
November 24, 2020
Proactively looking to provide industrial parks with facilities to grow API, pharma and nutra industry, said the Minister.
-
Sai Life Sciences opens representative office in Tokyo, Japan
expresspharma
November 23, 2020
Sai Life Sciences, an Indian Contract Research, Development & Manufacturing Organisation (CRO-CDMO), announced the opening of its representative office in Tokyo, Japan.
-
Onyx Scientific Invests in New Facility
contractpharma
November 18, 2020
Onyx Scientific is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
-
Cambrex Expands API Mfg. Capacity in Charles City
contractpharma
November 18, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa. The $50+ million investment aims to meet growing demand for small molecule drug substance development and manufacturing.